Chiara Cremolini

2009–2026 年に発表

186: 論文数
18,177: 被引用数
65: h 指数
165: i10 指数

被引用数

引用元

国・地域

0%18.2%その他 24.6%

機関

分野

トピック

全論文

並び替え

検索で開く

Treatment of Metastatic Colorectal Cancer: ASCO Guideline
著者: Van K. Morris, Erin B. Kennedy, Nancy N. Baxter, Al B. Benson, Andrea Cercek, May Cho, Kristen K. Ciombor, Chiara Cremolini, Anjee Davis, Dustin A. Deming, Marwan Fakih, Sepideh Gholami, Theodore S. Hong, Ishmael Jaiyesimi, Kelsey Klute, Christopher H. Lieu, Hanna K. Sanoff, John H. Strickler, Sarah B. White, Jason Willis, Cathy Eng - Journal of Clinical Oncology 2022 被引用: 602
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
著者: Marwan Fakih, Lisa Salvatore, Taito Esaki, Dominik Paul Modest, D. Páez López-Bravo, Julien Taı̈eb, Michalis V. Karamouzis, Erika Ruíz‐García, Tae‐Won Kim, Yasutoshi Kuboki, Fausto Meriggi, David Cunningham, Kun‐Huei Yeh, Emily Chan, Joseph Chao, Yaneth Saportas, Qui Tran, Chiara Cremolini, Filippo Pietrantonio - New England Journal of Medicine 2023 被引用: 342
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
著者: Gerald W. Prager, Julien Taı̈eb, Marwan Fakih, Fortunato Ciardiello, Eric Van Cutsem, Elena Élez, Felipe Melo Cruz, Lucjan Wyrwicz, Daniil Stroyakovskiy, Zsuzsanna Pápai, Pierre-Guillaume Poureau, Gábor Liposits, Chiara Cremolini, Igor Bondarenko, Dominik Paul Modest, Karim A. Benhadji, Nadia Amellal, Catherine Leger, Loïck Vidot, Josep Tabernero - New England Journal of Medicine 2023 被引用: 428
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
著者: John H. Strickler, Andrea Cercek, Salvatore Siena, Thierry André, Kimmie Ng, Eric Van Cutsem, Christina Wu, Andrew Scott Paulson, Joleen M. Hubbard, Andrew L. Coveler, Christos Fountzilas, Adel Kardosh, Pashtoon Murtaza Kasi, Heinz‐Josef Lenz, Kristen K. Ciombor, Elena Élez, David L. Bajor, Chiara Cremolini, Federico Sanchez, Michael Stecher, Wentao Feng, Tanios Bekaii‐Saab, Eric Van Cutsem, Marc Peeters, Marc Van den Evnde, Thierry André, Christophe Borg, Matthieu Sarabi, François Ghiringhelli, Benoist Chibaudel, Salvatore Siena, Chiara Cremolini, Maria Giulia Zampino, Elena Élez, Susana R. Keranen, Ramón Salazar, Pilar Alfonso, John H. Strickler, Andrea Cercek, Kimmie Ng, Christina Wu, Andrew Scott Paulson, Joleen M. Hubbard, Andrew L. Coveler, Christos Fountzilas, Adel Kardosh, Pashtoon Murtaza Kasi, Heinz‐Josef Lenz, Kristen K. Ciombor, David L. Bajor, Tanios Bekaii‐Saab, Olumide B. Gbolahan, Patrick M. Boland, Daniel Berg, Federico Sanchez, Timothy F. Goggins, Federico Sanchez, Howard A. Burris, Johanna C. Bendell, Darryl Outlaw, Isaac Tafur, Ardaman Shergill, Daniel V.T. Catenacci, Jun Gong, Ignacio Garrido‐Laguna, Gene Grant Finley, Benjamin A. Weinberg, Anthony F. Shields, Philip Philip, Anita Turk, Anthony Nguyen, Fadi Braiteh, Vijay Patel, William Harwin, Ian Anderson, Ajay Kundra, Christopher S. Chen, James M. Ford, Madappa N. Kundranda, Danny Nguyen, Suresh Ratnam, Donald Richards, Sujatha Nallapareddy, Sridhar Beeram, Scott McKenney, Spencer H. Shao, Scott McKenney, Spencer H. Shao - The Lancet Oncology 2023 被引用: 245
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials
著者: Giovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti, Federica Morano, Roberto Moretto, Salvatore Corallo, Federica Marmorino, Sara Lonardi, Lorenza Rimassa, Andrea Sartore‐Bianchi, Beatrice Borelli, Marco Tampellini, Sara Bustreo, Matteo Claravezza, Alessandra Boccaccino, Roberto Murialdo, Alberto Zaniboni, Gianluca Tomasello, Fotios Loupakis, Vincenzo Adamo, Giuseppe Tonini, Enrico Cortesi, Filippo de Braud, Chiara Cremolini, Filippo Pietrantonio - British Journal of Cancer 2020 被引用: 354
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
著者: Arvind Dasari, Sara Lonardi, Rocio García‐Carbonero, Elena Élez, Takayuki Yoshino, Alberto Sobrero, James C. Yao, Pilar García‐Alfonso, Judit Kocsis, Antonio Cubillo Gracián, Andrea Sartore‐Bianchi, Taroh Satoh, Violaine Randrian, Jiří Tomášek, Geoff Chong, Andrew Scott Paulson, Toshiki Masuishi, Jeremy Jones, Tibor Csőszi, Chiara Cremolini, François Ghiringhelli, Ardaman Shergill, Howard S. Höchster, John C. Krauss, Ali Bassam, Michel Ducreux, Anneli Elme, Laurence Faugeras, Stefan Kasper, Eric Van Cutsem, Dirk Arnold, Shivani Nanda, Zhao Yang, William R. Schelman, Marek Kania, Josep Tabernero, Cathy Eng - The Lancet 2023 被引用: 323
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
著者: Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio, Aurélie Catteau, Lisa Salvatore, Sara Lonardi, Isabelle Boquet, Stefano Tamberi, Federica Marmorino, Roberto Moretto, Margherita Ambrosini, Emiliano Tamburini, Giampaolo Tortora, Alessandro Passardi, Francesca Bergamo, Alboukadel Kassambara, Thomas Sbarrato, Federica Morano, Giuliana Ritorto, Beatrice Borelli, Alessandra Boccaccino, Veronica Conca, Mirella Giordano, Clara Ugolini, Jacques Fieschi, Alexia Papadopulos, Clémentine Massoué, Giuseppe Aprile, Lorenzo Antonuzzo, Fabio Gelsomino, Erika Martinelli, Nicoletta Pella, Gianluca Masi, Gabriella Fontanini, Luca Boni, Jérôme Galon, Chiara Cremolini - The Lancet Oncology 2022 被引用: 270
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome
著者: Lisa Derosa, Valerio Iebba, Carolina Alves Costa Silva, Gianmarco Piccinno, Guojun Wu, Leonardo Lordello, Bertrand Routy, Naisi Zhao, Cassandra Thélémaque, Roxanne Birebent, Federica Marmorino, Marine Fidelle, Meriem Messaoudene, Andrew Maltez Thomas, Gérard Zalcman, S. Friard, Julien Mazières, Clarisse Audigier-Valette, Denis Moro‐Sibilot, François Goldwasser, Arnaud Scherpereel, Hervé Pegliasco, François Ghiringhelli, Nicole Bouchard, Cissé Sow, Ines Darik, Silvia Zoppi, Pierre Ly, Anna Reni, Romain Daillère, Éric Deutsch, Karla A. Lee, Laura A. Bolte, Johannes R. Björk, Rinse K. Weersma, Fabrice Barlési, Lucas Padilha, Ana Finzel, Morten L. Isaksen, Bernard Escudier, Laurence Albigès, David Planchard, Fabrice André, Chiara Cremolini, Stéphanie Martinez, Benjamin Besse, Liping Zhao, Nicola Segata, Jérôme Wojcik, Guido Kroemer, Laurence Zitvogel - Cell 2024 被引用: 181
Colorectal cancer
著者: Cathy Eng, Takayuki Yoshino, Erika Ruíz‐García, Nermeen Mostafa, Christopher Cann, Brittany O'Brian, Amala Benny, Rodrigo Oliva Perez, Chiara Cremolini - The Lancet 2024 被引用: 356
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
著者: Jayesh Desai, Guzmán Alonso, Se Hyun Kim, Andrés Cervantes, Thomas B. Karasic, Laura Medina, Einat Shacham‐Shmueli, Rasha Cosman, Alejandro Falcón, Eelke Gort, Tormod Kyrre Guren, Erminia Massarelli, Wilson H. Miller, Luis Paz‐Ares, Hans Prenen, Alessio Amatu, Chiara Cremolini, Tae Won Kim, Víctor Moreno, Sai‐Hong Ignatius Ou, Alessandro Passardi, Adrian G. Sacher, Armando Santoro, Rafał Stec, Susanna V. Ulahannan, Kathryn C. Arbour, Patricia LoRusso, Jia Luo, Manish R. Patel, Yoonha Choi, Zhen Shi, Sandhya Mandlekar, Mark T. Lin, Stephanie Royer‐Joo, Julie Chang, Tomi Jun, Neekesh V. Dharia, Jennifer L. Schutzman, GO42144 Investigator and Study Group, Sae-Won Han - Nature Medicine 2023 被引用: 122
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
著者: Giulia Siravegna, Benedetta Mussolin, Michela Buscarino, Giorgio Corti, Andrea Cassingena, Giovanni Crisafulli, Agostino Ponzetti, Chiara Cremolini, Alessio Amatu, Calogero Lauricella, Simona Lamba, Sebastijan Hobor, Antonio Avallone, Emanuele Valtorta, Giuseppe Rospo, Enzo Médico, Valentina Motta, Carlotta Antoniotti, Fabiana Tatangelo, Beatríz Bellosillo, Silvio Veronese, Alfredo Budillon, Clara Montagut, Patrizia Racca, Silvia Marsoni, Alfredo Falcone, Ryan B. Corcoran, Federica Di Nicolantonio, Fotios Loupakis, Salvatore Siena, Andrea Sartore‐Bianchi, Alberto Bardelli - Nature Medicine 2015 被引用: 1,096
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan
著者: Chiara Cremolini, Daniele Rossini, Emanuela Dell’Aquila, Sara Lonardi, Elena Conca, Marzia Del Re, Adele Busico, Filippo Pietrantonio, Romano Danesi, Giuseppe Aprile, Emiliano Tamburini, Carlo Barone, Gianluca Masi, Francesco Pantano, Francesca Pucci, Domenico Corsi, Nicoletta Pella, Francesca Bergamo, Eleonora Rofi, C. Barbara, Alfredo Falcone, Daniele Santini - JAMA Oncology 2018 被引用: 420
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
著者: Chiara Cremolini, Fotios Loupakis, Carlotta Antoniotti, Cristiana Lupi, Elisa Sensi, Sara Lonardi, Silvia Mezi, Gianluca Tomasello, Monica Ronzoni, Alberto Zaniboni, Giuseppe Tonini, Chiara Carlomagno, Giacomo Allegrini, Silvana Chiara, Mauro D’Amico, Cristina Granetto, Marina Elena Cazzaniga, Luca Boni, Gabriella Fontanini, Alfredo Falcone - The Lancet Oncology 2015 被引用: 1,093
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
著者: Fotios Loupakis, Chiara Cremolini, Gianluca Masi, Sara Lonardi, Vittorina Zagonel, Lisa Salvatore, Enrico Cortesi, Gianluca Tomasello, Monica Ronzoni, Rosella Spadi, Alberto Zaniboni, Giuseppe Tonini, Angela Buonadonna, D. Amoroso, Silvana Chiara, Chiara Carlomagno, C. Boni, Giacomo Allegrini, Luca Boni, Alfredo Falcone - New England Journal of Medicine 2014 被引用: 1,078
Quantitative evidence for early metastatic seeding in colorectal cancer
著者: Zheng Hu, Jie Ding, Zhicheng Ma, Ruping Sun, José A. Seoane, J. Scott Shaffer, Carlos J. Suarez, Anna S. Berghoff, Chiara Cremolini, Alfredo Falcone, Fotios Loupakis, Peter Birner, Matthias Preusser, Heinz‐Josef Lenz, Christina Curtis - Nature Genetics 2019 被引用: 524
Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer
著者: Erika Martinelli, Giulia Martini, Vincenzo Famiglietti, Teresa Troiani, Stefania Napolitano, Filippo Pietrantonio, Davide Ciardiello, M. Terminiello, C. Borrelli, Pietro Paolo Vitiello, Filippo de Braud, Federica Morano, Antonio Avallone, Nicola Normanno, Anna Nappi, Evaristo Maiello, Tiziana Pia Latiano, Alfredo Falcone, Chiara Cremolini, Daniele Rossini, Giuseppe Santabarbara, Carmine Pinto, Daniele Santini, Claudia Cardone, N. Zanaletti, Alessandra Di Liello, Daniela Renato, Lucia Esposito, Francesca Marrone, Fortunato Ciardiello - JAMA Oncology 2021 被引用: 185
Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer
著者: Chiara Cremolini, Carlotta Antoniotti, Alexander Stein, Johanna C. Bendell, Thomas Gruenberger, Daniele Rossini, Gianluca Masi, Elena Ongaro, Herbert I. Hurwitz, Alfredo Falcone, Hans‐Joachim Schmoll, Massimo Di Maïo - Journal of Clinical Oncology 2020 被引用: 236
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine–DNA Methyltransferase–Silenced Metastatic Colorectal Cancer: The MAYA Trial
著者: Federica Morano, Alessandra Raimondi, Filippo Pagani, Sara Lonardi, Lisa Salvatore, Chiara Cremolini, Sabina Murgioni, Giovanni Randon, Federica Palermo, Lorenzo Antonuzzo, Nicoletta Pella, Patrizia Racca, Michele Prisciandaro, Monica Niger, Francesca Corti, Francesca Bergamo, Alberto Zaniboni, Margherita Ratti, Michele Palazzo, Celeste Cagnazzo, Maria Alessandra Calegari, Federica Marmorino, Iolanda Capone, Elena Conca, Adele Busico, Silvia Brich, Elena Tamborini, Federica Perrone, Massimo Di Maïo, Massimo Milione, Maria Di Bartolomeo, Filippo de Braud, Filippo Pietrantonio - Journal of Clinical Oncology 2022 被引用: 129
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer
著者: Elena Élez, Javier Ros, J. Fernández, Guillermo Villacampa, Ana Belén Moreno-Cárdenas, Carlota Arenillas, Kinga Bernatowicz, R. Comas, Shanshan Li, David P. Kodack, Roberta Fasani, Ariadna García, Javier Gonzalo‐Ruiz, Alejandro Piris‐Giménez, Paolo Nucíforo, Gráinne Kerr, Rossana Intini, Aldo Montagna, Marco Maria Germani, Giovanni Randon, Ana Vivancos, Ron Smits, Diana Graus, Raquel Pérez-López, Chiara Cremolini, Sara Lonardi, Filippo Pietrantonio, Rodrigo Dienstmann, Josep Tabernero, Rodrigo A. Toledo - Nature Medicine 2022 被引用: 111
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
著者: Giovanni Fucà, Romain Cohen, Sara Lonardi, Kohei Shitara, María Elena Elez, Marwan Fakih, Joseph Chao, Samuel J. Klempner, Matthew J. Emmett, Priya Jayachandran, Francesca Bergamo, M. Díez García, Giacomo Mazzoli, Leonardo Provenzano, Raphaël Colle, Magali Svrcek, Margherita Ambrosini, Giovanni Randon, Aakash Tushar Shah, Massimiliano Salati, Elisabetta Fenocchio, Lisa Salvatore, Keigo Chida, Akihito Kawazoe, Veronica Conca, Giuseppe Curigliano, Francesca Corti, Chiara Cremolini, Michael J. Overman, Thierry André, Filippo Pietrantonio - Journal for ImmunoTherapy of Cancer 2022 被引用: 120
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial
著者: Chiara Cremolini, Carlotta Antoniotti, Daniele Rossini, Sara Lonardi, Fotios Loupakis, Filippo Pietrantonio, Roberto Bordonaro, Tiziana Pia Latiano, Emiliano Tamburini, Daniele Santini, Alessandro Passardi, Federica Marmorino, Roberta Grande, Giuseppe Aprile, Alberto Zaniboni, Sabina Murgioni, Cristina Granetto, Angela Buonadonna, Roberto Moretto, Salvatore Corallo, Stefano Cordio, Lorenzo Antonuzzo, Gianluca Tomasello, Gianluca Masi, Monica Ronzoni, Samantha Di Donato, Chiara Carlomagno, Matteo Clavarezza, Giuliana Ritorto, Andrea Mambrini, Mario Roselli, Samanta Cupini, Serafina Mammoliti, Elisabetta Fenocchio, E. Corgna, Vittorina Zagonel, Gabriella Fontanini, Clara Ugolini, Luca Boni, Alfredo Falcone, Alfredo Falcone, Sara Lonardi, Filippo de Braud, Roberto Bordonaro, Evaristo Maiello, Emiliano Tamburini, Daniele Santini, Giovanni Luca Frassineti, Teresa Gamucci, Giuseppe Aprile, Alberto Zaniboni, Cristina Granetto, Angela Buonadonna, Francesco Di Costanzo, Gianluca Tomasello, Luca Gianni, Samantha Di Donato, Chiara Carlomagno, Matteo Clavarezza, Patrizia Racca, Andrea Mambrini, Mario Roselli, Giacomo Allegrini, Alberto Sobrero, Massimo Aglietta, E. Corgna, Enrico Cortesi, Domenico Corsi, Alberto Ballestrero, Andrea Bonetti, Francesco Clemente, Enzo Maria Ruggeri, Fortunato Ciardiello, Marco Benasso, S. Vitello, Saverio Cinieri, Stefania Mosconi, Nicola Silvestris, Antonio Frassoldati, S. Cupini, Alessandro Bertolini, Giampaolo Tortora, Carmelo Bengala, Daris Ferrari, Antonia Ardizzoia, Carlo Milandri, Silvana Chiara, Gianpiero Romano, Stefania Miraglia, Laura Scaltriti, Francesca Pucci, Livio Blasi, Silvia Brugnatelli, Luisa Fioretto, Angela Stefania Ribecco, Raffaella Longarini, M. Frisinghelli, Maria Banzi - The Lancet Oncology 2020 被引用: 325
Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
著者: Giulia Siravegna, Benedetta Mussolin, Michela Buscarino, Giorgio Corti, Andrea Cassingena, Giovanni Crisafulli, Agostino Ponzetti, Chiara Cremolini, Alessio Amatu, Calogero Lauricella, Simona Lamba, Sebastijan Hobor, Antonio Avallone, Emanuele Valtorta, Giuseppe Rospo, Enzo Médico, Valentina Motta, Carlotta Antoniotti, Fabiana Tatangelo, Beatríz Bellosillo, Silvio Veronese, Alfredo Budillon, Clara Montagut, Patrizia Racca, Silvia Marsoni, Alfredo Falcone, Ryan B. Corcoran, Federica Di Nicolantonio, Fotios Loupakis, Salvatore Siena, Andrea Sartore‐Bianchi, Alberto Bardelli - Nature Medicine 2015 被引用: 263
KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis
著者: Vincenzo Formica, Francesco Sera, Chiara Cremolini, Silvia Riondino, Cristina Morelli, Hendrik‐Tobias Arkenau, Mario Roselli - JNCI Journal of the National Cancer Institute 2021 被引用: 114
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO
著者: Daniele Rossini, Carlotta Antoniotti, Sara Lonardi, Filippo Pietrantonio, Roberto Moretto, Lorenzo Antonuzzo, Alessandra Boccaccino, Federica Morano, Marco Brugia, Carmelo Pozzo, Federica Marmorino, Francesca Bergamo, Emiliano Tamburini, Alessandro Passardi, Giovanni Randon, Sabina Murgioni, Beatrice Borelli, Angela Buonadonna, Mirella Giordano, Gabriella Fontanini, Veronica Conca, Vincenzo Formica, Massimo Aglietta, Roberto Bordonaro, Giuseppe Aprile, Gianluca Masi, Luca Boni, Chiara Cremolini - Journal of Clinical Oncology 2022 被引用: 78